0001567619-23-001594.txt : 20230201 0001567619-23-001594.hdr.sgml : 20230201 20230201112158 ACCESSION NUMBER: 0001567619-23-001594 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230201 DATE AS OF CHANGE: 20230201 EFFECTIVENESS DATE: 20230201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Precision Neuroscience Corp CENTRAL INDEX KEY: 0001858288 IRS NUMBER: 862458440 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-467851 FILM NUMBER: 23575413 BUSINESS ADDRESS: STREET 1: 54 W. 21ST ST. STREET 2: SUITE 310 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 646-771-5881 MAIL ADDRESS: STREET 1: 54 W. 21ST ST. STREET 2: SUITE 310 CITY: NEW YORK STATE: NY ZIP: 10010 D/A 1 primary_doc.xml X0708 D/A LIVE 0001858288 Precision Neuroscience Corp 54 W. 21st St. Suite 310 New York NY NEW YORK 10010 646-771-5881 DELAWARE None None Corporation true 2020 Michael Mager 54 W. 21st St. Suite 310 New York NY NEW YORK 10010 Executive Officer Director Chief Executive Officer Benjamin Rapoport 54 W. 21st St. Suite 310 New York NY NEW YORK 10010 Executive Officer Director President, Chief Science Officer and Secretary Craig Mermel 54 W. 21st St. Suite 310 New York NY NEW YORK 10010 Executive Officer Director Chief Product Officer Jason Chen 54 W. 21st St. Suite 310 New York NY NEW YORK 10010 Director Ravi Mehta 54 W. 21st St. Suite 310 New York NY NEW YORK 10010 Director Eric M. Attias 54 W. 21st St. Suite 310 New York NY NEW YORK 10010 Director Howard Morgan 54 W. 21st St. Suite 310 New York NY NEW YORK 10010 Director Other Health Care Decline to Disclose 06b true 0001567619-22-021752 2022-12-05 false true false 0 42000000 41150023 849977 false 20 0 0 0 false Precision Neuroscience Corp /s/ Michael Mager Michael Mager Chief Executive Officer 2023-02-01